Executive Intelligence

Bobby Reddy Jr

Founder

Bobby Reddy Jr is listed as a founder of Prenosis based in United States on Brel Digital’s verified company intelligence record.

In this profile

Quick Facts

  • Role Founder
  • Company Prenosis
  • Country United States
  • Industry AI in Healthcare
  • Founded 2014
  • Known For Prenosis achieved the first FDA De Novo marketing authorization for an AI sepsis diagnostic — a…
  • Status Active
  • Last Reviewed Jul 2026

Executive Summary

Bobby Reddy Jr appears in Brel Digital’s verified company_founders attribution for Prenosis based in United States in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted. Company context (from the verified Prenosis profile): Chicago digital health company whose FDA-authorized Sepsis ImmunoScore AI diagnostic integrates into acute-care EMR workflows Why the company matters (verified company field): Prenosis achieved the first FDA De Novo marketing authorization for an AI sepsis diagnostic — a regulatory milestone that tests whether acute-care AI can move from alert fatigue toward transparent, workflow-integrated clinical decision support with explainable risk scoring. Official company website on file: https://prenosis.com. Readers should consult that site and the Sources section for primary evidence. Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.

Career Timeline

Verified company milestones linked to this executive’s organization.

  1. 2014 Company founded

    Prenosis was founded in 2014 per the company profile source on file.

    Source
  2. 2014 Leadership

    2014: Prenosis founded in Chicago; Bobby Reddy Jr, PhD, is Co-Founder and CEO.

    Source
  3. 2024 Development

    April 3, 2024: FDA granted De Novo marketing authorization for Sepsis ImmunoScore u2014 first AI sepsis diagnostic cleared.

    Source
  4. 2024 Development

    April 10, 2024: Prenosis announced commercial distribution collaboration with Roche for Sepsis ImmunoScore.

    Source

Connected Company

Connected Products

Connected Reports

Connected Insights

Industry Intelligence

Bobby Reddy Jr appears in Brel Digital’s verified company_founders attribution for Prenosis based in United States in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted.

Company context (from the verified Prenosis profile): Chicago digital health company whose FDA-authorized Sepsis ImmunoScore AI diagnostic integrates into acute-care EMR workflows

Why the company matters (verified company field): Prenosis achieved the first FDA De Novo marketing authorization for an AI sepsis diagnostic — a regulatory milestone that tests whether acute-care AI can move from alert fatigue toward transparent, workflow-integrated clinical decision support with explainable risk scoring.

Official company website on file: https://prenosis.com. Readers should consult that site and the Sources section for primary evidence.

Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

The AI Brief

Founder and company intelligence, weekly.

Subscribe